The presence of cardiac metastasis has not been extensively evaluated in these patients presenting with increased BNP levels; BNP has been found to be a sensitive marker denoting cardiac metastasis in patients with non-small-cell lung cancer (N-SCLC) [7]. This evidence concerns the gene NPPB and metastasis.